Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jian Xu
Observed names:
J L Xu,
Jia ling Xu,
Jian-Lun Xu
Institution:
Zhejiang Chinese Medical University
Observed institutions:
Zhejiang Chinese Medical University,
Zhejiang Lab,
Jiangsu Province Hospital,
Second Affiliated Hospital of Zhejiang University,
First Affiliated Hospital Zhejiang University,
University of Houston,
Zhejiang University
show all 7
ORCID:
0000-0001-8132-8988
Observed ORCID:
0000-0001-8132-8988
OpenAlex ID:
A5100760825
NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1
2021
·
Xiaozhen Zhang
, Xing Huang
, et al.
·
Nature Communications
·
139
Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
2022
·
Xiaozhen Zhang
, Mengyi Lao
, et al.
·
Journal for ImmunoTherapy of Cancer
·
95
Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
2020
·
Xing Huang
, Enliang Li
, et al.
·
Frontiers in Cell and Developmental Biology
·
90
PDF
Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
2022
·
Hanshen Yang
, Xiaozhen Zhang
, et al.
·
Cell Death and Differentiation
·
88
PDF
Targeting cancer-associated fibroblast autophagy renders pancreatic cancer eradicable with immunochemotherapy by inhibiting adaptive immune resistance
2024
·
Xiaozhen Zhang
, Mengyi Lao
, et al.
·
Autophagy
·
83
Non-cytomembrane PD-L1: An atypical target for cancer
2021
·
Honggang Ying
, Xiaozhen Zhang
, et al.
·
Pharmacological Research
·
57
PDF
Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix
2023
·
Yi Duan
, Xiaozhen Zhang
, et al.
·
Oncogene
·
53
PDF
Combined targeted therapy and immunotherapy for cancer treatment
2021
·
Cheng-Xiang Guo
, Xing Huang
, et al.
·
World Journal of Clinical Cases
·
32
PDF
Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy
2022
·
Honggang Ying
, Jian Xu
, et al.
·
EBioMedicine
·
26
PDF
Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells
2021
·
Mengyi Lao
, Xiaozhen Zhang
, et al.
·
Oncogene
·
23
PDF
Galectin-9 and PD-L1 Antibody Blockade Combination Therapy Inhibits Tumour Progression in Pancreatic Cancer
2023
·
Enliang Li
, Jian Xu
, et al.
·
Immunotherapy
·
18
The application of clinical pathways in laparoscopic cholecystectomy
2014
·
Min Zhang
, Shu-Yang Zhou
, et al.
·
Hepatobiliary & pancreatic diseases international
·
18
Estimating a Distribution Function of the Tumor Size at Metastasis
1998
·
Jian-Lun Xu
, Philip C. Prorok
·
Biometrics
·
18
The AKT-independent MET–V-ATPase–MTOR axis suppresses liver cancer vaccination
2020
·
Xing Huang
, Xingyuan Xu
, et al.
·
Signal Transduction and Targeted Therapy
·
15
PDF
Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity
2020
·
Xing Huang
, Xiaozhen Zhang
, et al.
·
Frontiers in Oncology
·
14
PDF
Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy
2020
·
Xing Huang
, Tianyu Tang
, et al.
·
npj Precision Oncology
·
13
PDF
Tumor-Associated Macrophage in Breast Tumor Microenvironment
2025
·
Lingyao Ma
, Yuexinzi Jin
, et al.
·
International Journal of Molecular Sciences
·
8
PDF
Selective depletion of tumor-associated SAMHD1 enhances chemotherapeutic efficacy and antitumor immune responses
2025
·
Jing Sun
, Wenwen Zheng
, et al.
·
Signal Transduction and Targeted Therapy
·
7
PDF
Single-cell RNA sequencing uncovers an immunosuppressive program in PDAC mast cells: tumour-driven activation, proliferation, and association with Treg recruitment
2026
·
Mengli Wu
, XuXia Ye
, et al.
·
Annals of Medicine
PDF
[Effect of SMARCA4 mutations on the outcomes of patients with advanced EGFR mutant lung adenocarcinoma].
2025
·
X Liang
, Y Q Jiang
, et al.
·
PubMed
Show more works
View as search
Works count:
20
Citation count:
795
H-index:
14
I10-index:
16
Year
Topic
Type